Computer-assisted engineering of hyperstable fibroblast growth factor 2

Area of Science:

• Biotechnology and Protein Engineering
• Molecular Biology and Biochemistry

Background:

• Fibroblast Growth Factors (FGFs) are crucial regulatory proteins with significant therapeutic potential.
• The clinical application of FGFs is hindered by their inherent instability.

Purpose of the Study:

• To engineer a stabilized variant of Fibroblast Growth Factor 2 (FGF2) with improved stability and retained biological activity.
• To validate the efficacy of computer-assisted protein engineering strategies for protein stabilization.

Main Methods:

• Employed a generalizable computer-assisted protein engineering approach.
• Introduced nine specific mutations into the FGF2 protein sequence.
• Characterized the stability and biological function of the engineered FGF2 variant.

Main Results:

• Successfully created a modified FGF2 with nine mutations exhibiting unprecedented stability.
• The engineered FGF2 demonstrated uncompromised biological function.
• In silico predictions for protein stability were remarkably accurate, providing insights into unfolding mechanisms.

Conclusions:

• Computer-assisted protein engineering is a powerful strategy for overcoming protein instability.
• The stabilized FGF2 variant shows significant promise for applications in stem cell research.
• This engineered molecule holds potential for future medical and pharmaceutical advancements.